NorthView Acquisition Corp - Warrants (02/08/2027)
NVACW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$87.44M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $87.44 Million |
|---|---|
| Enterprise Value | $93.52 Million |
| Earnings per Share | $-107.01 |
| Beta | 0.49 |
| Outstanding Shares | 794,920,000 |
Return
| Return on Equity | -560.20% |
|---|---|
| Return on Assets | -151.15% |
| Return on Invested Capital | -203.34% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.9 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.82 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Profusa, Inc. Common Stock
2 employees
CEO: Ben Chung-Bin Hwang
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia